FROM SINGLE USE TO CIRCULAR USE Increased attention from Governments, health services and industry evolving policy and regulatory frameworks
With
Jane Crowe, Vice President Asia Pacific
Cardinal Health
Neroli Manning
Managing Director, ANZ at Cardinal Health
Dan Vukelich, CEO and President,
Association of Medical Device Reprocessors (AMDR)
SEGMENT
Filmed in Sydney | September 2026
Healthcare sustainability is increasingly becoming a strategic priority, extending beyond environmental goals to influence procurement, regulation, costs and supply-chain resilience. Against this backdrop, medical device reprocessing is emerging as a potential pathway towards a more circular healthcare system.
In September 2026 at the RegConnect26 Summit, hosted by the Medical Technology Association of Australia, Dan Vukelich, President and CEO of the Association of Medical Device Reprocessors, outlined the international evolution of reprocessing, remanufacturing and refurbishment of single-use medical devices (SUDs).
Drawing on more than two decades of experience across the United States, Europe and other major healthcare markets, Vukelich explored how these models are increasingly influencing sustainability strategies, procurement policies and regulatory frameworks. Reprocessing can help reduce medical waste and emissions while improving resource efficiency and strengthening supply-chain resilience.
In an interview with Australian Health Journal, Vukelich was joined by Jane Crowe and Neroli Manning from Cardinal Health, a global medical device and healthcare company. The discussion examined the company’s experience in the United States and its plans to establish a remanufacturing facility in Newcastle.
Expected to open in 2027, the facility will be among the few in Australia capable of remanufacturing single-use medical devices, with products returned to circulation following quality testing and high-level disinfection processes.
Vukelich highlighted the need for greater regulatory clarity around cleaning validation, cycle limits and demonstrating that reprocessed devices meet medical device manufacturing standards. “These devices are as safe and as effective as original equipment,” he said.
The speakers also identified opportunities for Australia to develop green MedTech manufacturing capabilities and potentially expand sustainable healthcare solutions across the Asia-Pacific region.
– Media access credit: RegConnect 2026 Summit | Medical Technology Association of Australia (MTAA)
– PowerPoint slides supplied by Association of Medical Device Reprocessors (AMDR)
Source: Written by Australian Health Journal using AI
-
Understanding extracellular vesicles in cancer therapy research
Joy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland.
Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics.
-
The world of AI avatars in dementia care
Dementia care is one of the critical issues facing the aged care industry. About 500,000 Australians currently live with the brain disorder condition, and this is tipped to rise to 1.1 million in a generation.
How to effectively provide quality care for people living with dementia was a key element of the royal commission into aged care, which found the complex care required was an ongoing challenge for the industry.
-
CASE STUDY: Evolution in the medical device supply chain
For Cardinal Health, a global manufacturer and distributor of medical products, the process begins when products arrive in Australia and are cleared by customs before being stored at their Sydney warehouse. From here, they fulfil orders for various clients, including hospitals and wholesalers, supported by DHL’s logistics services.
